Caribou Biosciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+1.3% +$478K
$-37M
Free Cash Flow↑+82.9% +$558K
$-115K
Investing Cash Flow↑+12.8% +$2M
$18M
Financing Cash Flow↑+5.4% +$207K
$4M
Capex↓-82.9% -$558K
$115K
Stock-Based Comp↓-30.0% -$1M
$3M
D&A↓-42.4% -$502K
$682K
SBC Allocated Expense↓-30.0% -$1M
$3M